Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 22367 | 384 | 54.3 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
| 49 | 3 | ALZHEIMERS DISEASE//AMYOTROPHIC LATERAL SCLEROSIS//DEMENTIA | 92146 |
| 35 | 2 | ALZHEIMERS DISEASE//AMYLOID PRECURSOR PROTEIN//TAU | 32531 |
| 22367 | 1 | CELLULAR NEUROSCI NEURODEGENERAT REPAIR PROGRAM//AMYLOID BETA PEPTIDE 25 35//AMYLOID BETA PROTEIN OLIGOMERS | 384 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | CELLULAR NEUROSCI NEURODEGENERAT REPAIR PROGRAM | address | 194811 | 2% | 35% | 7 |
| 2 | AMYLOID BETA PEPTIDE 25 35 | authKW | 165657 | 1% | 42% | 5 |
| 3 | AMYLOID BETA PROTEIN OLIGOMERS | authKW | 106023 | 1% | 67% | 2 |
| 4 | APPSWE PS1 DELTA E9 | authKW | 106023 | 1% | 67% | 2 |
| 5 | INSIDE OUT MEMBRANE PATCH | authKW | 106023 | 1% | 67% | 2 |
| 6 | FUNCT BIOCHEM NERVOUS SYST | address | 84186 | 2% | 18% | 6 |
| 7 | 6 PHOSPHONOMETHYL DECA HYDROISOQUINOLINE 3 CARBOXYLIC ACID | authKW | 79518 | 0% | 100% | 1 |
| 8 | A BETA 43 | authKW | 79518 | 0% | 100% | 1 |
| 9 | A BETA DISPOSAL | authKW | 79518 | 0% | 100% | 1 |
| 10 | A BETA INDUCED DEPRESSION | authKW | 79518 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Neurosciences | 5703 | 70% | 0% | 267 |
| 2 | Geriatrics & Gerontology | 293 | 5% | 0% | 19 |
| 3 | Biochemistry & Molecular Biology | 132 | 19% | 0% | 74 |
| 4 | Behavioral Sciences | 120 | 4% | 0% | 17 |
| 5 | Clinical Neurology | 44 | 6% | 0% | 24 |
| 6 | Pharmacology & Pharmacy | 30 | 8% | 0% | 30 |
| 7 | Medicine, Research & Experimental | 29 | 4% | 0% | 17 |
| 8 | Cell Biology | 22 | 6% | 0% | 23 |
| 9 | Physiology | 18 | 3% | 0% | 13 |
| 10 | Psychology | 9 | 2% | 0% | 6 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CELLULAR NEUROSCI NEURODEGENERAT REPAIR PROGRAM | 194811 | 2% | 35% | 7 |
| 2 | FUNCT BIOCHEM NERVOUS SYST | 84186 | 2% | 18% | 6 |
| 3 | BIOCHIM 2001 Z8 | 79518 | 0% | 100% | 1 |
| 4 | BRAIN SWISS FED TECHNOL | 79518 | 0% | 100% | 1 |
| 5 | CANADIAN HLTH GRP VASC COGNIT IMPAIRMENT | 79518 | 0% | 100% | 1 |
| 6 | CARDIOLALBERT SZENT GYORGYI MED PHARMACEUT | 79518 | 0% | 100% | 1 |
| 7 | CIN S CYCERON | 79518 | 0% | 100% | 1 |
| 8 | CREAT INITIAT ALZHEIMERS DEMENTIA RE | 79518 | 0% | 100% | 1 |
| 9 | DECADIMENTO COGNIT | 79518 | 0% | 100% | 1 |
| 10 | ENDOCRINOL NEUROETHOL | 79518 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | PRION | 11472 | 2% | 2% | 8 |
| 2 | JOURNAL OF ALZHEIMERS DISEASE | 5681 | 5% | 0% | 18 |
| 3 | MOLECULAR BRAIN | 2425 | 1% | 1% | 4 |
| 4 | NEUROBIOLOGY OF AGING | 1975 | 3% | 0% | 12 |
| 5 | JOURNAL OF NEUROSCIENCE | 1564 | 7% | 0% | 26 |
| 6 | MOLECULAR NEUROBIOLOGY | 1287 | 2% | 0% | 6 |
| 7 | MOLECULAR NEURODEGENERATION | 1277 | 1% | 1% | 3 |
| 8 | NEUROBIOLOGY OF LEARNING AND MEMORY | 913 | 1% | 0% | 5 |
| 9 | ALZHEIMERS RESEARCH & THERAPY | 902 | 1% | 1% | 2 |
| 10 | CURRENT ALZHEIMER RESEARCH | 751 | 1% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | HAAS, LT , SALAZAR, SV , KOSTYLEV, MA , UM, JW , KAUFMAN, AC , STRITTMATTER, SM , (2016) METABOTROPIC GLUTAMATE RECEPTOR 5 COUPLES CELLULAR PRION PROTEIN TO INTRACELLULAR SIGNALLING IN ALZHEIMER'S DISEASE.BRAIN. VOL. 139. ISSUE . P. 526 -546 | 28 | 38% | 5 |
| 2 | SCOTT-MCKEAN, JJ , SUREWICZ, K , CHOI, JK , RUFFIN, VA , SALAMEH, AI , NIEZNANSKI, K , COSTA, ACS , SUREWICZ, WK , (2016) SOLUBLE PRION PROTEIN AND ITS N-TERMINAL FRAGMENT PREVENT IMPAIRMENT OF SYNAPTIC PLASTICITY BY A BETA OLIGOMERS: IMPLICATIONS FOR NOVEL THERAPEUTIC STRATEGY IN ALZHEIMER'S DISEASE.NEUROBIOLOGY OF DISEASE. VOL. 91. ISSUE . P. 124 -131 | 18 | 50% | 3 |
| 3 | KALEKA, KS , GERGES, NZ , (2016) NEUROGRANIN RESTORES AMYLOID BETA-MEDIATED SYNAPTIC TRANSMISSION AND LONG-TERM POTENTIATION DEFICITS.EXPERIMENTAL NEUROLOGY. VOL. 277. ISSUE . P. 115 -123 | 22 | 39% | 1 |
| 4 | KUDO, W , PETERSEN, RB , LEE, HG , (2013) CELLULAR PRION PROTEIN AND ALZHEIMER DISEASE LINK TO OLIGOMERIC AMYLOID-BETA AND NEURONAL CELL DEATH.PRION. VOL. 7. ISSUE 2. P. 114-116 | 14 | 64% | 6 |
| 5 | DANYSZ, W , PARSONS, CG , (2012) ALZHEIMER'S DISEASE, BETA-AMYLOID, GLUTAMATE, NMDA RECEPTORS AND MEMANTINE - SEARCHING FOR THE CONNECTIONS.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 167. ISSUE 2. P. 324-352 | 38 | 17% | 101 |
| 6 | RISSE, E , NICOLL, AJ , TAYLOR, WA , WRIGHT, D , BADONI, M , YANG, XF , FARROW, MA , COLLINGE, J , (2015) IDENTIFICATION OF A COMPOUND THAT DISRUPTS BINDING OF AMYLOID-BETA TO THE PRION PROTEIN USING A NOVEL FLUORESCENCE-BASED ASSAY.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 290. ISSUE 27. P. 17020 -17028 | 18 | 41% | 5 |
| 7 | HU, NW , NICOLL, AJ , ZHANG, DN , MABLY, AJ , O'MALLEY, T , PURRO, SA , TERRY, C , COLLINGE, J , WALSH, DM , ROWAN, MJ , (2014) MGLU5 RECEPTORS AND CELLULAR PRION PROTEIN MEDIATE AMYLOID-BETA-FACILITATED SYNAPTIC LONG-TERM DEPRESSION IN VIVO.NATURE COMMUNICATIONS. VOL. 5. ISSUE . P. - | 18 | 38% | 20 |
| 8 | UM, JW , NYGAARD, HB , HEISS, JK , KOSTYLEV, MA , STAGI, M , VORTMEYER, A , WISNIEWSKI, T , GUNTHER, EC , STRITTMATTER, SM , (2012) ALZHEIMER AMYLOID-BETA OLIGOMER BOUND TO POSTSYNAPTIC PRION PROTEIN ACTIVATES FYN TO IMPAIR NEURONS.NATURE NEUROSCIENCE. VOL. 15. ISSUE 9. P. 1227 -U85 | 16 | 31% | 151 |
| 9 | BELAND, M , BEDARD, M , TREMBLAY, G , LAVIGNE, P , ROUCOU, X , (2014) A BETA INDUCES ITS OWN PRION PROTEIN N-TERMINAL FRAGMENT (PRPN1)-MEDIATED NEUTRALIZATION IN AMORPHOUS AGGREGATES.NEUROBIOLOGY OF AGING. VOL. 35. ISSUE 7. P. 1537-1548 | 20 | 35% | 7 |
| 10 | FALKER, C , HARTMANN, A , GUETT, I , DOHLER, F , ALTMEPPEN, H , BETZEL, C , SCHUBERT, R , THURM, D , WEGWITZ, F , JOSHI, P , ET AL (2016) EXOSOMAL CELLULAR PRION PROTEIN DRIVES FIBRILLIZATION OF AMYLOID BETA AND COUNTERACTS AMYLOID BETA-MEDIATED NEUROTOXICITY.JOURNAL OF NEUROCHEMISTRY. VOL. 137. ISSUE 1. P. 88 -100 | 17 | 27% | 6 |
Classes with closest relation at Level 1 |